Cygna Labs, a subsidiary of the Cygna Labs Group, has acquired Diamond IP, from BT (formerly British Telecom). Cygna Labs is a highly specialized software manufacturer with a focus on providing enterprises worldwide with the latest innovations in cloud security and compliance technology.
With this strategic acquisition, Cygna Labs is adding the third largest DDI vendor to its product portfolio and transforms Diamond IP into a standalone software vendor – thereby enabling the Cygna Labs Group to strengthen its DDI product and managed service offerings for its customers.
Diamond IP is a critical provider of connectivity, cloud, and security services, which will now be in a position again to drive innovation in the DDI market. The acquisition not only provides significant intellectual property, but also allows the group to gain some of the foremost DDI experts in the world as part of its team. The entire Diamond IP workforce will join Cygna Labs as part of this transaction – which underpins why Christian Ehrenthal, president and CEO of Cygna Labs, is so enthusiastic: “Closing this acquisition represents a major milestone for both Cygna Labs and the Diamond IP team. We are excited to welcome our new colleagues as well as a large number of Fortune 100 customers, which we have the privilege of securing as part of this transaction.” Pleased that a suitable partner could be found, Michael Dooley, Senior VP of DDI adds: “We speak the same language and share the same values. I am convinced that Cygna Labs is a good home for all Diamond IP employees.”
Alexander Häcker, CEO of Cygna Labs Group commented: “With this acquisition, we further solidify our DDI expertise and enlarge our team to more than 150 industry experts. This enables us to deliver world-class products and services to our valued customers around the globe regardless of their current DDI platform.”
Eduard Reder, Director at INVISION, welcomes the new partnership: “I am delighted that, with Diamond IP, we have secured world-leading DDI expertise. The acquisition of Diamond IP is transformational for our group and evidence of confidence in the combined team.”
Details of the transaction are confidential and will not be disclosed. Cygna Labs was advised on this transaction by BDO UK LLP (M&A), Hogan Lovells (legal), Warth & Klein Grant Thornton (finance & tax), BARC (commercial), Marsh (insurance) and King & Wood Mallesons (financing).
About Cygna Labs
Cygna Labs is a software developer and one of the top three global DDI vendors. Many Fortune 100 customers rely on Cygna Labs’ DDI products and services, in addition to its industry-leading security and compliance solutions to detect and proactively mitigate data security threats, affordably pass compliance audits, and increase the productivity of their IT departments.
Further information can be found on www.cygnalabs.com
About Diamond IP
Diamond IP delivers the world’s most integrated and reliable IP address management appliances, software and managed services to meet the most demanding technical and business requirements. The product offers maximum flexibility to manage DDI with IPControl software, Sapphire hardware and virtual appliances, cloud automation, extensive DNS threat protection, as well as IPAM managed services.
Further information can be found on www.cygnalabs.com/en/diamond-ip-platform
Since its foundation in 1997, INVISION has successfully developed into one of Europe’s leading investors for succession solutions and growth financing for medium-sized companies. During this time, INVISION has invested more than EUR 1 billion in over 60 companies and achieved sustainable valuation creation. INVISION acts as an entrepreneurial partner to entrepreneurs and management teams. As part of its growth levers, INVISION seeks to internationalize businesses, introduce new products and services as well as catalyze the internal digitalization process.
Further information can be found on www.invision.ch
INVISION BETEILIGUNGSBERATUNG GMBH
40212 Düsseldorf / Germany
Tel. +49 211 936 727 50 E-Mail: firstname.lastname@example.org